Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...
In headlines, spot rates slip 10% from holiday peak; Super Bowl hangovers cost businesses $3B; and a stolen chassis ring in ...